PAINscape—Exploring patient experiences with ketamine for chronic neuropathic pain: A qualitative study
Although pain experiences differed among participants, all participants reported decreased pain with ketamine infusions. Addressing the stigma associated with ketamine infusions, further research around augmenting durability of ketamine, and providing a safe treatment environment can all improve ketamine's benefit for chronic neuropathic pain. Understanding the barriers and facilitators, as well as implementing participant suggestions, will not only help inform our ketamine program but can improve access to pain management and facilitate future research in this field.
Authors
- Cheryl Pritlove (ORCID: https://orcid.org/0000-0001-9627-7562)
- Nandana D. Parakh
- Hance Clarke (ORCID: https://orcid.org/0000-0003-4975-3823)
- Danielle Lessor
- Sakina J. Rizvi
- Paul Ritvo (ORCID: https://orcid.org/0000-0003-1141-0083)
- Kevin Dang (ORCID: https://orcid.org/0000-0002-6821-4238)
- Akash Goel (ORCID: https://orcid.org/0009-0007-5303-537X)
- Zaaria Thomas (ORCID: https://orcid.org/0009-0009-9402-9763)
- John G. Hanlon
- R. Nayar
- Janneth Pazmino-Canizares
- Sérgio M. Pereira
- Mindy Lu
- Victoria Tucci
- Mariela Leda
- Gabriella Mattina
- Duminda N. Wijeysundera
Institutions
- University Health Network (CA)
- 3M (United States) (US)
- University of British Columbia (CA)
- University of Toronto (CA)
- York University (CA)
- Toronto General Hospital (CA)
- St Michael’s Hospital (IE)
- Center for Anxiety and Depression (US)
- Unity Health Toronto
Publication Details
- Journal
- Canadian Journal of Pain
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1080/24740527.2026.2615473
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00